Author:
Correia Maria Almira,Ortiz de Montellano Paul R.
Reference630 articles.
1. Rahimtula, A.D. and P.J. O’Brien (1977). The peroxidase nature of cytochrome P450. In V. Ullrich, I. Roots, A. Hildebrandt, R.W. Estabrook, and A.H. Conney (eds.), Microsomes and Drug Oxidations, Pergamon Press, Elmsford, NY, pp. 210–217.
2. Rodrigues, A.D., D. Fernandez, M.A. Nosarzewski, W.M. Pierce, and R.A. Prough (1991). Inhibition of hepatic microsomal cytochrome P-450 dependent monooxygenation activity by the antioxidant 3-tert-butyl-4-hydroxyanisole. Chem. Res. Toxicol. 4, 281–289.
3. Kharasch, E.D., N.K. Wendel, and R.F. Novak (1987). Anthracenedione antineoplastic agent effects on drug metabolism in vitro and in vivo: Relationship between structure and mechanism of inhibition. Fundam. Appl. Toxicol. 9, 18–25.
4. Testa, B. and P. Jenner (1981). Inhibitors of cytochrome P-450s and their mechanism of action. Drug. Metab. Rev. 12, 1–117.
5. Correia, M.A., and P.R. Ortiz de Montellano (1993). Inhibitors of cytochrome P450 and possibilities for their therapeutic application. In K. Ruckpaul (ed.), Frontiers in Biotransformation. Akademie-Verlag, Berlin, pp. 74–146.
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献